Estimating Blood [Lactate] Non-Invasively

Not Applicable

Not yet recruiting

• Conditions: Healthy
• Interventions: Device: LabClasp

• Registration Number: NCT05036122
• Lead Sponsor: Mayo Clinic

Brief Summary

The purpose of this study is to validate the LabClasp's ability to estimate blood \[lactate\].

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-09-02
• Study First Submitted QC: 2021-09-02
• Study First Posted: 2021-09-05
• Status Verified: 2024-03
• Last Update Submitted: 2024-03-19
• Last Update Posted: 2024-03-20
• Study Start: 2025-02
• Primary Completion: 2025-09
• Study Completion: 2025-12

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Whole-body exercise in healthy adults (Aim 1)	LabClasp	Subjects will have blood \[lactate\] measurement obtained with the LabClasp device while completing an exercise stress test on a treadmill or bicycle.
ICU patients susceptible to developing sepsis (Aim 2)	LabClasp	Subjects will have blood \[lactate\] measurement obtained with the LabClasp device as frequently as required for clinical purposes

Primary Outcome Measures

Name	Time	Method
Blood [lactate] during incremental exercise	1 day	Measured via venous blood and the LabClasp
Blood [lactate] measurements in ICU patients	1 day	Measured via venous blood and the LabClasp

Trial Locations

Locations (1)

Mayo Clinic in Rochester; 🇺🇸 Rochester, Minnesota, United States